• 

  FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy, CLBR001 + SWI019

  The therapy is currently being evaluated as a treatment for B-cell malignancies, a class of blood cancers that includes non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

• 

  Unleashing the immune system’s ‘STING’ against cancer

  A small molecule that activates the immune protein STING shows promising results against tumors.

• 

  Scripps Research expands international effort to rapidly repurpose existing drugs against COVID-19

  An international research network centers around ReFRAME, the world’s leading collection of drugs known to be safe in humans.

• 

  Scripps Research scientists leveraging ReFRAME drug repurposing collection against COVID-19 coronavirus epidemic

  Calibr scientists work to repurpose existing drugs against novel coronavirus.

• 

  Calibr’s ‘switchable’ CAR-T platform for cancer moves forward with FDA clearance of Investigational New Drug application

  Having achieved this regulatory milestone, Calibr can begin clinical trials for its novel cell therapy candidate, which leverages a patient's own immune cells to treat cancer.

• 

  Scripps Research receives $50 million to advance therapies for tuberculosis, malaria and other global health challenges

  Renewed support from the Bill & Melinda Gates Foundation to accelerate research by Calibr, the drug development division of Scripps Research.

• 

  Calibr works with Cystic Fibrosis Foundation to find potential medicines for hard-to-treat lung infections

  Under a two-year contract and funding agreement, Calibr will screen its vast library of drug molecules for compounds that work against a rare but vexing family of bacteria.

• 

  One of the world’s largest collections of medicines is being mined for new treatments

  This video by Boston Globe’s STAT magazine features Calibr’s ReFRAME collection, a drug repurposing project that’s finding ways to treat new diseases with existing drugs.

• 

  ReFRAME drug repurposing collection yields hope for treating diseases that kill millions worldwide

  Calibr scientists build and deploy new ReFRAME drug collection to find potential therapies against HIV, tuberculosis and parasites that causes severe illness in children.

• 

  World-leading scientific research institute debuts new name and look

  Scripps Research is Science Changing Life